The main objective is to strengthen the biotechnology sector, through the maximisation of the benefits of life science infrastructures and skills for the development of the Atlantic Area, which has notable areas of excellence (notably in marine science, rich and increasing number of SMEs, policy initiatives) but also weaknesses.